Inogen, Inc.
Inogen, Inc. INGN Peers
See (INGN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INGN | $5.88 | -4.23% | 158.10M | -5.11 | -$1.15 | N/A |
| ABT | $128.56 | -0.38% | 223.67B | 16.70 | $7.70 | +1.78% |
| BSX-PA | $122.18 | +2.37% | 175.45B | 230.53 | $0.53 | N/A |
| BSX | $102.94 | -0.01% | 152.29B | 75.14 | $1.37 | N/A |
| SYK | $386.29 | -0.32% | 147.63B | 52.20 | $7.40 | +0.85% |
| MDT | $84.19 | -1.08% | 107.98B | 25.67 | $3.28 | +3.32% |
| EW | $76.71 | +1.60% | 45.00B | 31.70 | $2.42 | N/A |
| DXCM | $86.52 | +2.87% | 33.93B | 65.05 | $1.33 | N/A |
| PODD | $321.41 | +2.21% | 22.62B | 58.12 | $5.53 | N/A |
| STE | $227.49 | -1.58% | 22.35B | 36.57 | $6.22 | +0.98% |
Stock Comparison
INGN vs ABT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ABT has a market cap of 223.67B. Regarding current trading prices, INGN is priced at $5.88, while ABT trades at $128.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ABT's P/E ratio is 16.70. In terms of profitability, INGN's ROE is -0.15%, compared to ABT's ROE of +0.24%. Regarding short-term risk, INGN is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BSX-PA Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BSX-PA has a market cap of 175.45B. Regarding current trading prices, INGN is priced at $5.88, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, INGN's ROE is -0.15%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, INGN is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BSX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BSX has a market cap of 152.29B. Regarding current trading prices, INGN is priced at $5.88, while BSX trades at $102.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BSX's P/E ratio is 75.14. In terms of profitability, INGN's ROE is -0.15%, compared to BSX's ROE of +0.10%. Regarding short-term risk, INGN is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SYK Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SYK has a market cap of 147.63B. Regarding current trading prices, INGN is priced at $5.88, while SYK trades at $386.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SYK's P/E ratio is 52.20. In terms of profitability, INGN's ROE is -0.15%, compared to SYK's ROE of +0.11%. Regarding short-term risk, INGN is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs MDT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, MDT has a market cap of 107.98B. Regarding current trading prices, INGN is priced at $5.88, while MDT trades at $84.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas MDT's P/E ratio is 25.67. In terms of profitability, INGN's ROE is -0.15%, compared to MDT's ROE of +0.09%. Regarding short-term risk, INGN is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs EW Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, EW has a market cap of 45.00B. Regarding current trading prices, INGN is priced at $5.88, while EW trades at $76.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas EW's P/E ratio is 31.70. In terms of profitability, INGN's ROE is -0.15%, compared to EW's ROE of +0.49%. Regarding short-term risk, INGN is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs DXCM Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, DXCM has a market cap of 33.93B. Regarding current trading prices, INGN is priced at $5.88, while DXCM trades at $86.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas DXCM's P/E ratio is 65.05. In terms of profitability, INGN's ROE is -0.15%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, INGN is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs PODD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PODD has a market cap of 22.62B. Regarding current trading prices, INGN is priced at $5.88, while PODD trades at $321.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PODD's P/E ratio is 58.12. In terms of profitability, INGN's ROE is -0.15%, compared to PODD's ROE of +0.35%. Regarding short-term risk, INGN is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs STE Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, STE has a market cap of 22.35B. Regarding current trading prices, INGN is priced at $5.88, while STE trades at $227.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas STE's P/E ratio is 36.57. In terms of profitability, INGN's ROE is -0.15%, compared to STE's ROE of +0.07%. Regarding short-term risk, INGN is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs PHG Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PHG has a market cap of 22.08B. Regarding current trading prices, INGN is priced at $5.88, while PHG trades at $23.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PHG's P/E ratio is 82.31. In terms of profitability, INGN's ROE is -0.15%, compared to PHG's ROE of -0.06%. Regarding short-term risk, INGN is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ZBH Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ZBH has a market cap of 18.86B. Regarding current trading prices, INGN is priced at $5.88, while ZBH trades at $95.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ZBH's P/E ratio is 21.19. In terms of profitability, INGN's ROE is -0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, INGN is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ABMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ABMD has a market cap of 17.18B. Regarding current trading prices, INGN is priced at $5.88, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ABMD's P/E ratio is 65.36. In terms of profitability, INGN's ROE is -0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, INGN is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ALGN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ALGN has a market cap of 13.60B. Regarding current trading prices, INGN is priced at $5.88, while ALGN trades at $187.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ALGN's P/E ratio is 34.12. In terms of profitability, INGN's ROE is -0.15%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, INGN is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SWAV Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SWAV has a market cap of 12.57B. Regarding current trading prices, INGN is priced at $5.88, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SWAV's P/E ratio is 78.76. In terms of profitability, INGN's ROE is -0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, INGN is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SNN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SNN has a market cap of 12.24B. Regarding current trading prices, INGN is priced at $5.88, while SNN trades at $27.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SNN's P/E ratio is 29.77. In terms of profitability, INGN's ROE is -0.15%, compared to SNN's ROE of +0.08%. Regarding short-term risk, INGN is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs PEN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PEN has a market cap of 11.19B. Regarding current trading prices, INGN is priced at $5.88, while PEN trades at $288.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PEN's P/E ratio is 270.07. In terms of profitability, INGN's ROE is -0.15%, compared to PEN's ROE of +0.04%. Regarding short-term risk, INGN is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs GMED Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, GMED has a market cap of 7.88B. Regarding current trading prices, INGN is priced at $5.88, while GMED trades at $58.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas GMED's P/E ratio is 43.41. In terms of profitability, INGN's ROE is -0.15%, compared to GMED's ROE of +0.05%. Regarding short-term risk, INGN is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BIO-B Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BIO-B has a market cap of 6.86B. Regarding current trading prices, INGN is priced at $5.88, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, INGN's ROE is -0.15%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, INGN is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BIO Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BIO has a market cap of 6.44B. Regarding current trading prices, INGN is priced at $5.88, while BIO trades at $237.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BIO's P/E ratio is -3.10. In terms of profitability, INGN's ROE is -0.15%, compared to BIO's ROE of -0.32%. Regarding short-term risk, INGN is less volatile compared to BIO. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs BRKR Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BRKR has a market cap of 5.58B. Regarding current trading prices, INGN is priced at $5.88, while BRKR trades at $36.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BRKR's P/E ratio is 70.87. In terms of profitability, INGN's ROE is -0.15%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, INGN is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs GKOS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, GKOS has a market cap of 5.23B. Regarding current trading prices, INGN is priced at $5.88, while GKOS trades at $91.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas GKOS's P/E ratio is -40.34. In terms of profitability, INGN's ROE is -0.15%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, INGN is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs NARI Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NARI has a market cap of 4.68B. Regarding current trading prices, INGN is priced at $5.88, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NARI's P/E ratio is -59.24. In terms of profitability, INGN's ROE is -0.15%, compared to NARI's ROE of -0.18%. Regarding short-term risk, INGN is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs INSP Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, INSP has a market cap of 4.59B. Regarding current trading prices, INGN is priced at $5.88, while INSP trades at $155.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas INSP's P/E ratio is 69.54. In terms of profitability, INGN's ROE is -0.15%, compared to INSP's ROE of +0.10%. Regarding short-term risk, INGN is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs IRTC Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, IRTC has a market cap of 4.48B. Regarding current trading prices, INGN is priced at $5.88, while IRTC trades at $140.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas IRTC's P/E ratio is -44.88. In terms of profitability, INGN's ROE is -0.15%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, INGN is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ITGR Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ITGR has a market cap of 4.17B. Regarding current trading prices, INGN is priced at $5.88, while ITGR trades at $119.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ITGR's P/E ratio is 55.63. In terms of profitability, INGN's ROE is -0.15%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, INGN is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs TMDX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, TMDX has a market cap of 4.14B. Regarding current trading prices, INGN is priced at $5.88, while TMDX trades at $122.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas TMDX's P/E ratio is 86.17. In terms of profitability, INGN's ROE is -0.15%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, INGN is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs AXNX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AXNX has a market cap of 3.63B. Regarding current trading prices, INGN is priced at $5.88, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AXNX's P/E ratio is -709.80. In terms of profitability, INGN's ROE is -0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, INGN is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs PRCT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PRCT has a market cap of 3.03B. Regarding current trading prices, INGN is priced at $5.88, while PRCT trades at $54.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PRCT's P/E ratio is -32.41. In terms of profitability, INGN's ROE is -0.15%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, INGN is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs LIVN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, LIVN has a market cap of 2.37B. Regarding current trading prices, INGN is priced at $5.88, while LIVN trades at $43.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas LIVN's P/E ratio is -10.70. In terms of profitability, INGN's ROE is -0.15%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, INGN is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs NUVA Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NUVA has a market cap of 2.08B. Regarding current trading prices, INGN is priced at $5.88, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NUVA's P/E ratio is 75.00. In terms of profitability, INGN's ROE is -0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, INGN is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs UFPT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, UFPT has a market cap of 1.87B. Regarding current trading prices, INGN is priced at $5.88, while UFPT trades at $242.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas UFPT's P/E ratio is 29.76. In terms of profitability, INGN's ROE is -0.15%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, INGN is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ATEC Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ATEC has a market cap of 1.86B. Regarding current trading prices, INGN is priced at $5.88, while ATEC trades at $12.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ATEC's P/E ratio is -11.18. In terms of profitability, INGN's ROE is -0.15%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, INGN is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs CNMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CNMD has a market cap of 1.81B. Regarding current trading prices, INGN is priced at $5.88, while CNMD trades at $58.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CNMD's P/E ratio is 15.55. In terms of profitability, INGN's ROE is -0.15%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, INGN is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs TNDM Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, TNDM has a market cap of 1.52B. Regarding current trading prices, INGN is priced at $5.88, while TNDM trades at $22.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas TNDM's P/E ratio is -8.19. In terms of profitability, INGN's ROE is -0.15%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, INGN is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs HSKA Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, HSKA has a market cap of 1.31B. Regarding current trading prices, INGN is priced at $5.88, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas HSKA's P/E ratio is -62.49. In terms of profitability, INGN's ROE is -0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, INGN is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs AORT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AORT has a market cap of 1.24B. Regarding current trading prices, INGN is priced at $5.88, while AORT trades at $28.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AORT's P/E ratio is -56.82. In terms of profitability, INGN's ROE is -0.15%, compared to AORT's ROE of -0.07%. Regarding short-term risk, INGN is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs AHCO Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AHCO has a market cap of 1.20B. Regarding current trading prices, INGN is priced at $5.88, while AHCO trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AHCO's P/E ratio is 15.34. In terms of profitability, INGN's ROE is -0.15%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, INGN is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SILK Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SILK has a market cap of 1.12B. Regarding current trading prices, INGN is priced at $5.88, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SILK's P/E ratio is -18.96. In terms of profitability, INGN's ROE is -0.15%, compared to SILK's ROE of -0.37%. Regarding short-term risk, INGN is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs FNA Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, FNA has a market cap of 1.10B. Regarding current trading prices, INGN is priced at $5.88, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas FNA's P/E ratio is -19.83. In terms of profitability, INGN's ROE is -0.15%, compared to FNA's ROE of -0.36%. Regarding short-term risk, INGN is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ESTA Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ESTA has a market cap of 1.05B. Regarding current trading prices, INGN is priced at $5.88, while ESTA trades at $36.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ESTA's P/E ratio is -11.57. In terms of profitability, INGN's ROE is -0.15%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, INGN is less volatile compared to ESTA. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs INMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, INMD has a market cap of 1.01B. Regarding current trading prices, INGN is priced at $5.88, while INMD trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas INMD's P/E ratio is 6.53. In terms of profitability, INGN's ROE is -0.15%, compared to INMD's ROE of +0.25%. Regarding short-term risk, INGN is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs IART Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, IART has a market cap of 1.00B. Regarding current trading prices, INGN is priced at $5.88, while IART trades at $12.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas IART's P/E ratio is -34.00. In terms of profitability, INGN's ROE is -0.15%, compared to IART's ROE of -0.03%. Regarding short-term risk, INGN is less volatile compared to IART. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs CSII Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CSII has a market cap of 843.96M. Regarding current trading prices, INGN is priced at $5.88, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CSII's P/E ratio is -20.83. In terms of profitability, INGN's ROE is -0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, INGN is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs CRY Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CRY has a market cap of 725.15M. Regarding current trading prices, INGN is priced at $5.88, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CRY's P/E ratio is 425.71. In terms of profitability, INGN's ROE is -0.15%, compared to CRY's ROE of -0.07%. Regarding short-term risk, INGN is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SIBN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SIBN has a market cap of 719.58M. Regarding current trading prices, INGN is priced at $5.88, while SIBN trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SIBN's P/E ratio is -22.60. In terms of profitability, INGN's ROE is -0.15%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, INGN is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs IRMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, IRMD has a market cap of 660.04M. Regarding current trading prices, INGN is priced at $5.88, while IRMD trades at $51.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas IRMD's P/E ratio is 33.49. In terms of profitability, INGN's ROE is -0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, INGN is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BFLY-WT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BFLY-WT has a market cap of 630.11M. Regarding current trading prices, INGN is priced at $5.88, while BFLY-WT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, INGN's ROE is -0.15%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, INGN is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs CBLL Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CBLL has a market cap of 594.91M. Regarding current trading prices, INGN is priced at $5.88, while CBLL trades at $16.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CBLL's P/E ratio is -5.02. In terms of profitability, INGN's ROE is -0.15%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, INGN is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs APEN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, APEN has a market cap of 579.72M. Regarding current trading prices, INGN is priced at $5.88, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas APEN's P/E ratio is -9.43. In terms of profitability, INGN's ROE is -0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, INGN is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BFLY Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BFLY has a market cap of 566.29M. Regarding current trading prices, INGN is priced at $5.88, while BFLY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BFLY's P/E ratio is -7.63. In terms of profitability, INGN's ROE is -0.15%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, INGN is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs KIDS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, KIDS has a market cap of 565.97M. Regarding current trading prices, INGN is priced at $5.88, while KIDS trades at $22.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas KIDS's P/E ratio is -12.98. In terms of profitability, INGN's ROE is -0.15%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, INGN is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs AVNS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AVNS has a market cap of 561.17M. Regarding current trading prices, INGN is priced at $5.88, while AVNS trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AVNS's P/E ratio is -1.47. In terms of profitability, INGN's ROE is -0.15%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, INGN is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs AXGN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AXGN has a market cap of 538.33M. Regarding current trading prices, INGN is priced at $5.88, while AXGN trades at $11.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AXGN's P/E ratio is -73.87. In terms of profitability, INGN's ROE is -0.15%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, INGN is less volatile compared to AXGN. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs RXST Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, RXST has a market cap of 538.03M. Regarding current trading prices, INGN is priced at $5.88, while RXST trades at $13.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas RXST's P/E ratio is -20.06. In terms of profitability, INGN's ROE is -0.15%, compared to RXST's ROE of -0.10%. Regarding short-term risk, INGN is less volatile compared to RXST. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs NPCE Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NPCE has a market cap of 510.94M. Regarding current trading prices, INGN is priced at $5.88, while NPCE trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NPCE's P/E ratio is -16.77. In terms of profitability, INGN's ROE is -0.15%, compared to NPCE's ROE of -2.58%. Regarding short-term risk, INGN is less volatile compared to NPCE. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs OFIX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, OFIX has a market cap of 468.99M. Regarding current trading prices, INGN is priced at $5.88, while OFIX trades at $11.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas OFIX's P/E ratio is -3.24. In terms of profitability, INGN's ROE is -0.15%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, INGN is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BVS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BVS has a market cap of 423.36M. Regarding current trading prices, INGN is priced at $5.88, while BVS trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BVS's P/E ratio is -13.57. In terms of profitability, INGN's ROE is -0.15%, compared to BVS's ROE of -0.21%. Regarding short-term risk, INGN is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs TMCI Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, TMCI has a market cap of 422.72M. Regarding current trading prices, INGN is priced at $5.88, while TMCI trades at $6.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas TMCI's P/E ratio is -7.91. In terms of profitability, INGN's ROE is -0.15%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, INGN is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs SRDX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SRDX has a market cap of 399.38M. Regarding current trading prices, INGN is priced at $5.88, while SRDX trades at $27.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SRDX's P/E ratio is -19.95. In terms of profitability, INGN's ROE is -0.15%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, INGN is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs SENS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SENS has a market cap of 374.71M. Regarding current trading prices, INGN is priced at $5.88, while SENS trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SENS's P/E ratio is -5.21. In terms of profitability, INGN's ROE is -0.15%, compared to SENS's ROE of -7.46%. Regarding short-term risk, INGN is less volatile compared to SENS. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs NNOX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NNOX has a market cap of 357.70M. Regarding current trading prices, INGN is priced at $5.88, while NNOX trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NNOX's P/E ratio is -6.16. In terms of profitability, INGN's ROE is -0.15%, compared to NNOX's ROE of -0.30%. Regarding short-term risk, INGN is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs CLPT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CLPT has a market cap of 347.79M. Regarding current trading prices, INGN is priced at $5.88, while CLPT trades at $12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CLPT's P/E ratio is -17.76. In terms of profitability, INGN's ROE is -0.15%, compared to CLPT's ROE of -0.62%. Regarding short-term risk, INGN is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs CTKB Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CTKB has a market cap of 345.78M. Regarding current trading prices, INGN is priced at $5.88, while CTKB trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CTKB's P/E ratio is -30.33. In terms of profitability, INGN's ROE is -0.15%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, INGN is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs PACB Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PACB has a market cap of 330.09M. Regarding current trading prices, INGN is priced at $5.88, while PACB trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PACB's P/E ratio is -0.40. In terms of profitability, INGN's ROE is -0.15%, compared to PACB's ROE of -1.25%. Regarding short-term risk, INGN is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs OM Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, OM has a market cap of 327.86M. Regarding current trading prices, INGN is priced at $5.88, while OM trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas OM's P/E ratio is -0.64. In terms of profitability, INGN's ROE is -0.15%, compared to OM's ROE of -1.45%. Regarding short-term risk, INGN is less volatile compared to OM. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs SMLR Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SMLR has a market cap of 312.27M. Regarding current trading prices, INGN is priced at $5.88, while SMLR trades at $32.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SMLR's P/E ratio is 6.34. In terms of profitability, INGN's ROE is -0.15%, compared to SMLR's ROE of +0.35%. Regarding short-term risk, INGN is less volatile compared to SMLR. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs VREX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, VREX has a market cap of 309.18M. Regarding current trading prices, INGN is priced at $5.88, while VREX trades at $7.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas VREX's P/E ratio is -7.23. In terms of profitability, INGN's ROE is -0.15%, compared to VREX's ROE of -0.08%. Regarding short-term risk, INGN is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs VMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, VMD has a market cap of 271.53M. Regarding current trading prices, INGN is priced at $5.88, while VMD trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas VMD's P/E ratio is 22.90. In terms of profitability, INGN's ROE is -0.15%, compared to VMD's ROE of +0.10%. Regarding short-term risk, INGN is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ZIMV Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ZIMV has a market cap of 243.48M. Regarding current trading prices, INGN is priced at $5.88, while ZIMV trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ZIMV's P/E ratio is -9.69. In terms of profitability, INGN's ROE is -0.15%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, INGN is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs CERS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CERS has a market cap of 238.95M. Regarding current trading prices, INGN is priced at $5.88, while CERS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CERS's P/E ratio is -12.50. In terms of profitability, INGN's ROE is -0.15%, compared to CERS's ROE of -0.35%. Regarding short-term risk, INGN is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs MXCT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, MXCT has a market cap of 233.90M. Regarding current trading prices, INGN is priced at $5.88, while MXCT trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas MXCT's P/E ratio is -6.11. In terms of profitability, INGN's ROE is -0.15%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, INGN is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs NVRO Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NVRO has a market cap of 224.09M. Regarding current trading prices, INGN is priced at $5.88, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NVRO's P/E ratio is -1.91. In terms of profitability, INGN's ROE is -0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, INGN is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs TCMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, TCMD has a market cap of 222.72M. Regarding current trading prices, INGN is priced at $5.88, while TCMD trades at $9.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas TCMD's P/E ratio is 14.30. In terms of profitability, INGN's ROE is -0.15%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, INGN is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs EYES Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, EYES has a market cap of 210.05M. Regarding current trading prices, INGN is priced at $5.88, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas EYES's P/E ratio is N/A. In terms of profitability, INGN's ROE is -0.15%, compared to EYES's ROE of -0.26%. Regarding short-term risk, INGN is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BWAY Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BWAY has a market cap of 193.82M. Regarding current trading prices, INGN is priced at $5.88, while BWAY trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BWAY's P/E ratio is 57.06. In terms of profitability, INGN's ROE is -0.15%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, INGN is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs BDMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, BDMD has a market cap of 185.40M. Regarding current trading prices, INGN is priced at $5.88, while BDMD trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas BDMD's P/E ratio is 14.94. In terms of profitability, INGN's ROE is -0.15%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, INGN is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs RCEL Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, RCEL has a market cap of 176.85M. Regarding current trading prices, INGN is priced at $5.88, while RCEL trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas RCEL's P/E ratio is -3.05. In terms of profitability, INGN's ROE is -0.15%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, INGN is less volatile compared to RCEL. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs LNSR Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, LNSR has a market cap of 167.21M. Regarding current trading prices, INGN is priced at $5.88, while LNSR trades at $14.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas LNSR's P/E ratio is -2.92. In terms of profitability, INGN's ROE is -0.15%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, INGN is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs QTRX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, QTRX has a market cap of 166.19M. Regarding current trading prices, INGN is priced at $5.88, while QTRX trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas QTRX's P/E ratio is -3.45. In terms of profitability, INGN's ROE is -0.15%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, INGN is less volatile compared to QTRX. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs ELMD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ELMD has a market cap of 165.45M. Regarding current trading prices, INGN is priced at $5.88, while ELMD trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ELMD's P/E ratio is 25.78. In terms of profitability, INGN's ROE is -0.15%, compared to ELMD's ROE of +0.16%. Regarding short-term risk, INGN is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs ANIK Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ANIK has a market cap of 162.34M. Regarding current trading prices, INGN is priced at $5.88, while ANIK trades at $11.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ANIK's P/E ratio is -14.33. In terms of profitability, INGN's ROE is -0.15%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, INGN is less volatile compared to ANIK. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs CATX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CATX has a market cap of 160.33M. Regarding current trading prices, INGN is priced at $5.88, while CATX trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CATX's P/E ratio is -1.77. In terms of profitability, INGN's ROE is -0.15%, compared to CATX's ROE of -0.27%. Regarding short-term risk, INGN is less volatile compared to CATX. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs TLSI Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, TLSI has a market cap of 158.44M. Regarding current trading prices, INGN is priced at $5.88, while TLSI trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas TLSI's P/E ratio is -3.74. In terms of profitability, INGN's ROE is -0.15%, compared to TLSI's ROE of +1.14%. Regarding short-term risk, INGN is less volatile compared to TLSI. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs SGHT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, SGHT has a market cap of 157.67M. Regarding current trading prices, INGN is priced at $5.88, while SGHT trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas SGHT's P/E ratio is -2.96. In terms of profitability, INGN's ROE is -0.15%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, INGN is less volatile compared to SGHT. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs MASS Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, MASS has a market cap of 154.40M. Regarding current trading prices, INGN is priced at $5.88, while MASS trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas MASS's P/E ratio is -2.04. In terms of profitability, INGN's ROE is -0.15%, compared to MASS's ROE of -0.13%. Regarding short-term risk, INGN is less volatile compared to MASS. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs AVR Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, AVR has a market cap of 147.35M. Regarding current trading prices, INGN is priced at $5.88, while AVR trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas AVR's P/E ratio is -2.07. In terms of profitability, INGN's ROE is -0.15%, compared to AVR's ROE of -4.16%. Regarding short-term risk, INGN is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs CVRX Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, CVRX has a market cap of 137.92M. Regarding current trading prices, INGN is priced at $5.88, while CVRX trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas CVRX's P/E ratio is -2.47. In terms of profitability, INGN's ROE is -0.15%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, INGN is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs LUCD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, LUCD has a market cap of 134.89M. Regarding current trading prices, INGN is priced at $5.88, while LUCD trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas LUCD's P/E ratio is -1.22. In terms of profitability, INGN's ROE is -0.15%, compared to LUCD's ROE of -4.60%. Regarding short-term risk, INGN is less volatile compared to LUCD. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs RPID Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, RPID has a market cap of 131.49M. Regarding current trading prices, INGN is priced at $5.88, while RPID trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas RPID's P/E ratio is -2.78. In terms of profitability, INGN's ROE is -0.15%, compared to RPID's ROE of -0.56%. Regarding short-term risk, INGN is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs LUNG Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, LUNG has a market cap of 131.24M. Regarding current trading prices, INGN is priced at $5.88, while LUNG trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas LUNG's P/E ratio is -2.26. In terms of profitability, INGN's ROE is -0.15%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, INGN is less volatile compared to LUNG. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs PROF Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, PROF has a market cap of 121.41M. Regarding current trading prices, INGN is priced at $5.88, while PROF trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas PROF's P/E ratio is -3.34. In terms of profitability, INGN's ROE is -0.15%, compared to PROF's ROE of -0.62%. Regarding short-term risk, INGN is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs MYO Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, MYO has a market cap of 117.29M. Regarding current trading prices, INGN is priced at $5.88, while MYO trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas MYO's P/E ratio is -23.29. In terms of profitability, INGN's ROE is -0.15%, compared to MYO's ROE of -0.36%. Regarding short-term risk, INGN is more volatile compared to MYO. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ICAD Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ICAD has a market cap of 107.31M. Regarding current trading prices, INGN is priced at $5.88, while ICAD trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ICAD's P/E ratio is -18.62. In terms of profitability, INGN's ROE is -0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, INGN is less volatile compared to ICAD. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs HJLI Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, HJLI has a market cap of 98.32M. Regarding current trading prices, INGN is priced at $5.88, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas HJLI's P/E ratio is N/A. In terms of profitability, INGN's ROE is -0.15%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, INGN is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs ASXC Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, ASXC has a market cap of 94.92M. Regarding current trading prices, INGN is priced at $5.88, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas ASXC's P/E ratio is -1.12. In terms of profitability, INGN's ROE is -0.15%, compared to ASXC's ROE of -4.07%. Regarding short-term risk, INGN is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.
INGN vs XTNT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, XTNT has a market cap of 89.17M. Regarding current trading prices, INGN is priced at $5.88, while XTNT trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas XTNT's P/E ratio is -5.33. In terms of profitability, INGN's ROE is -0.15%, compared to XTNT's ROE of -0.27%. Regarding short-term risk, INGN is less volatile compared to XTNT. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs OWLT Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, OWLT has a market cap of 89.07M. Regarding current trading prices, INGN is priced at $5.88, while OWLT trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas OWLT's P/E ratio is -3.35. In terms of profitability, INGN's ROE is -0.15%, compared to OWLT's ROE of +1.37%. Regarding short-term risk, INGN is less volatile compared to OWLT. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs MGRM Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, MGRM has a market cap of 88.22M. Regarding current trading prices, INGN is priced at $5.88, while MGRM trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas MGRM's P/E ratio is -4.90. In terms of profitability, INGN's ROE is -0.15%, compared to MGRM's ROE of -1.29%. Regarding short-term risk, INGN is less volatile compared to MGRM. This indicates potentially lower risk in terms of short-term price fluctuations for INGN.
INGN vs NVCN Comparison
INGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INGN stands at 158.10M. In comparison, NVCN has a market cap of 82.86M. Regarding current trading prices, INGN is priced at $5.88, while NVCN trades at $30.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INGN currently has a P/E ratio of -5.11, whereas NVCN's P/E ratio is -1.99. In terms of profitability, INGN's ROE is -0.15%, compared to NVCN's ROE of -1.21%. Regarding short-term risk, INGN is more volatile compared to NVCN. This indicates potentially higher risk in terms of short-term price fluctuations for INGN.